CORONA, CA, Jan 06, 2009 (MARKET WIRE via COMTEX News Network) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, announced today that Paul Bisaro, Watson's
president and chief executive officer, will provide an overview and
update of the Company's business at the JP Morgan 27th Annual
Healthcare Conference on Monday, January 12, 2009 at 9:00 a.m.
Pacific Standard Time.
This presentation will be webcast live and can be accessed on Watson
Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 60 days after the live
presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is
a leading specialty pharmaceutical company that develops,
manufactures, markets, sells and distributes generic and specialty
brand pharmaceutical products. Watson pursues a growth strategy
combining internal product development, strategic alliances and
collaborations and synergistic acquisitions of products and
For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals